Earnings Release2026-04-20
Icure Pharm. Amendment
아이큐
아이큐어
175250
Signal Score
50C — Neutral
Score50 / 100
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=2406
Risk-adjusted indicator based on 2406 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Revenue: 82,838 million KRW (2025), 50,017 million KRW (2024), 35,162 million KRW (2023)
- • Operating Profit: Not disclosed
3 more figures — unlock with API access
AI Analysis Summary
Developer & Pro plans
Risk Factors
Developer & Pro plans
Access Full Korean Market Signal Analytics
✔ AI-parsed DART filing classification & scoring
✔ Real-time event impact indicators
✔ Historical pattern data via REST API
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.
AI-processed analysis. Based on: [기재정정]사업보고서 (2025.12). Source: Financial Supervisory Service (금융감독원 전자공시시스템). Raw government data is not redistributed. Not investment advice.